| Type-2 diabetes as a risk factor for severe COVID-19 infection M Norouzi, S Norouzi, A Ruggiero, MS Khan, S Myers, K Kavanagh, ... Microorganisms 9 (6), 1211, 2021 | 59 | 2021 |
| Synthesis, molecular docking study, and anticancer activity of triaryl-1, 2, 4-oxadiazole P Miralinaghi, M Salimi, A Amirhamzeh, M Norouzi, HM Kandelousi, ... Medicinal Chemistry Research 22, 4253-4262, 2013 | 40 | 2013 |
| Nervous system involvement in COVID-19: a review of the current knowledge M Norouzi, P Miar, S Norouzi, P Nikpour Molecular Neurobiology 58, 3561-3574, 2021 | 18 | 2021 |
| Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways S Norouzi, M Norouzi, M Amini, A Amanzadeh, M Nabiuni, S Irian, ... DARU Journal of Pharmaceutical Sciences 24, 1-9, 2016 | 18 | 2016 |
| Apoptotic effects of two cox‐2 inhibitors on breast adenocarcinoma cells through COX‐2 independent pathway M Norouzi, S Norouzi, M Amini, A Amanzadeh, S Irian, M Salimi Journal of Cellular Biochemistry 116 (1), 81-90, 2015 | 18 | 2015 |
| Corona virus disease 2019 (COVID-19) as a system-level infectious disease with distinct sex disparities M Emadi-Baygi, M Ehsanifard, N Afrashtehpour, M Norouzi, ... Frontiers in Immunology 12, 778913, 2021 | 8 | 2021 |
| WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family M Norouzi, M Shafiei, Z Abdollahi, P Miar, H Galehdari, MH Emami, ... Frontiers in Oncology 11, 648649, 2021 | 2 | 2021 |
| A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency M Hoseinzadeh, N Molavi, M Norouzi, S Aghaei, M Zeinalian, ... Laboratory Medicine 54 (4), 439-446, 2023 | 1 | 2023 |
| A Study on the DNA Cleavage, Morphological Changes and Cytotoxicity Activities of the Two Synthetic COX-2 Inhibitors M Norouzi, S Irian, A Divsalar, M Salimi Journal of Reports in Pharmaceutical Sciences 2 (1), 38-44, 2013 | 1 | 2013 |
| Genetics and Biological Characteristics of SARS-CoV-2 M Norouzi, MA Miles, S Norouzi Frontiers of COVID-19: Scientific and Clinical Aspects of the Novel …, 2022 | | 2022 |
| A Simplified Protocol for Microsatellite Instability Evaluation in Iranian Patients at Risk for Lynch Syndrome Z Abdollahi, MA Tabatabaiefar, M Noruzi, P Miar, M Kazemi, A Naimi, ... Laboratory Medicine 53 (3), 235-241, 2022 | | 2022 |
| BAT25, ACVR2, and TGFBR2 Mononucleotide STR Markers: A Triplex Panel for Microsatellite Instability Testing in Colorectal Tumors P Miar, MA Tabatabaiefar, Z Abdollahi, M Noruzi, M Kazemi, A Naimi, ... Advanced Biomedical Research 11 (1), 79, 2022 | | 2022 |
| New COX-2 inhibitor derivatives as potent anti-cancer agents M Salimi, M Amini, A Amanzadeh, M Norouzi, S Norouzi, A Afsharinasab, ... | | 2015 |
| COX-2 Inhibitor Derivatives Inhibit Cell Proliferation and Induce Apoptosis through COX-2 Independent Pathway in Breast Adenocarcinoma Cells M Norouzi, S Norouzi, M Amini, A Amanzadeh, S Irian, M Salimi | | 2014 |
| COX-2 independent induction of apoptosis by two synthetic COX-2 inhibitors in breast cancer cell line M Salimi, S Norouzi, M Norouzi, M Amini, A Amanzadeh University Of Tasmania, 2014 | | 2014 |
| COX-2 inhibitors prevent proliferation of breast cancer cells by inducing apoptosis M Salimi, M Norouzi, K Azadmanesh, A Amanzadeh, H Sanati, ... EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 50, E166-E166, 2013 | | 2013 |
| Evaluation of apoptosis induced by COX-2 inhibitors in leukemia and breast cancer cells S Norouzi, M Norouzi, S Ayerian, HM Kandelous, M Nabiuni, M Salimi University Of Tasmania, 2013 | | 2013 |
| University of Tasmania Open Access Repository Cover sheet S Norouzi, M Norouzi, S Ayerian, M Nabiuni, M Amini, M Salimi | | |
Shaghayegh NorouziMedical Scientist在 utas.edu.au 的电子邮件经过验证
